This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

1Department of Molecular Biology, Princeton University, Princeton, New Jersey. 2Ludwig Institute for Cancer Research Princeton Branch, Princeton, New Jersey.

Cancer Res (2025) 85 (1): 183–188. The Cancer Research editors wish to acknowledge with sincere appreciation the assistance of the following reviewers who have generously contributed their time and ...

Glutathione S-Transferase P (GSTP) known as a Phase II detoxification enzyme has more recently been identified as a modulator of MAP kinase-related cell-signaling pathways. It is known to be ...

1Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum – MKFZ, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany.

Innovent Biologics will license IBI3009, its investigational DLL3-targeted antibody–drug conjugate (ADC) for small cell lung cancer (SCLC), to Roche for $80 million upfront and payments totaling up to ...

Search for other works by this author on: ...

1Genome, Cell, and Developmental Biology, Department of Biology, Indiana University Bloomington, Bloomington, Indiana. 2Medical Sciences Program, Indiana University School of Medicine, Bloomington, ...

Publishing in July 2025 to coincide with the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, the series will continue through December 2025! Technological ...